- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 391 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- December 2024
- 200 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- June 2022
- 245 Pages
Global
From €3285EUR$3,456USD£2,760GBP
Lactamase is an enzyme that hydrolyzes β-lactam antibiotics, such as penicillins and cephalosporins, and is used to treat bacterial infections. It is a type of β-lactamase, which is an enzyme that breaks down the β-lactam ring of the antibiotic, rendering it ineffective. Lactamase is produced by many bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. It is also produced by some fungi, such as Aspergillus fumigatus.
The lactamase market is a growing industry, with a wide range of applications in the medical and pharmaceutical industries. It is used to treat bacterial infections, as well as to develop new antibiotics and other drugs. It is also used in research and development, to study the structure and function of enzymes.
Some companies in the lactamase market include Merck, Novozymes, Sigma-Aldrich, and Roche. Show Less Read more